{"ticker": {"uuid": "46b64fc3-6ab7-412f-bff4-c42888add959", "symbol": "4534", "name": "Mochida Pharmaceutical Co., Ltd.", "exchange": "JPX", "country": "JP", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Enterprise value to EBITDA forward of Mochida Pharmaceutical Co., Ltd. \u2013 TSE:4534", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOLW9iQW5HUmFSZWY1ZDZiRjgteU9vVWhaY3YzQ25EOFlWSEZweU4xTHZKcTlBckhjX3ltTmVVX0FUV1NLQ1pDeWEtME01ZUR6czFrbGhfcnBNSmIzVDJmMklCLXp2NF9GU29CYk5sZjVJWFRSMk9ES2tOY2lkREJSa1BZVEY3NkFlZVA5TkxFVkp5QXhqSWlIc1NJcElVcllnNnlhdXM0OWhfZw?oc=5", "source_name": "TradingView", "published_at": "2026-07-04T23:42:11+00:00", "published_display": "04 Jul 2026 23:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Mochida Pharmaceutical Co., Ltd. \u2013 TSE:4534", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQeUtqSTNfRGUxYlh6X25uVGFQbmMwb1YxOW9MUUlXRDE4UW03cWU5ZndmQ19xNHVEUWpRTi0wLWlMS0FPTDZxQTltTjJPMHpNY0t0aGExemxXT0FnRVR2U3gyZXdmbFRpbUdwdUlDa1BYMEo1VFNDSWF1RzdldXd1MGdOa2lVZi1VOVh2Yjh2UE9vVEtnakhwSQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-04T23:38:28+00:00", "published_display": "04 Jul 2026 23:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mochida shares lean on business context as investors await new signals.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOMTFMRmcxU3k3bGhxdXRma1g2NmtDUGFoWDNkT3M5Q2t0M09tZFQyM0EyUDJTbmJ5SmVkQ0lOZnA2N2FSVTg4ZlVvODJwQ0NfWGxlMFpWYjVkMzhiNENyeDlCbDRTdWlKdExkd3lGMHAtWllCSHVUdEMyczlzd252Y3BIMDlfN2ZjWkRad2NPUmVJaTJGX0FSajkya19yby0ydEF5aWdYcGp4UG5tcHZEa0YySXhXSWFnQkhXVEd0SUJDaXk5Ri1PMA?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T12:25:59+00:00", "published_display": "04 Jul 2026 12:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The CARP-III program from Mochida Pharmaceutical Co. - long-running B2B support for paediatric anaes", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNWmxXRmdBY2E2bjRZUklyX0N1ZDlkUDZDeVQ4OEFIdUpBU0VmcVkwSFBEMEczbzFxSkpGNmlUZDd2eGZDZjZZalo2UnpsYlJ4OTRVb21aUFNST0JOUWdYWFpCNzMwdVVYSlFEWlRpbnJ4MDZMbFdBQmpJWTh6a2MwdFNWTzRGc21lbHZSQmhYcUFuZ0Q3OVVFSUtSaG1ZNmV6clYtVGctZ1BiYW9kazYzdWlaTDNseUxkZEpCNEZucWl5WGpjRHc?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-27T23:11:17+00:00", "published_display": "27 Jun 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Mochida Pharmaceutical Co., Ltd. (TSE:4534)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5oeXFESW5wdENIamZtQVVxUWw4ZE5JbkpjZEluMkVGa3BoTWxPTlZzZlBPT1owcHVxY0ZvcV9fWERWajZBMXVFX0lIekt1SFV6ZUc0eW5tRzJpTUJEdzhEblNWek1SZVk?oc=5", "source_name": "TradingView", "published_at": "2018-02-02T23:10:44+00:00", "published_display": "02 Feb 2018 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Enterprise value to EBITDA forward of Mochida Pharmaceutical Co., Ltd. \u2013 TSE:4534", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOLW9iQW5HUmFSZWY1ZDZiRjgteU9vVWhaY3YzQ25EOFlWSEZweU4xTHZKcTlBckhjX3ltTmVVX0FUV1NLQ1pDeWEtME01ZUR6czFrbGhfcnBNSmIzVDJmMklCLXp2NF9GU29CYk5sZjVJWFRSMk9ES2tOY2lkREJSa1BZVEY3NkFlZVA5TkxFVkp5QXhqSWlIc1NJcElVcllnNnlhdXM0OWhfZw?oc=5", "source_name": "TradingView", "published_at": "2026-07-04T23:42:11+00:00", "published_display": "04 Jul 2026 23:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Mochida Pharmaceutical Co., Ltd. \u2013 TSE:4534", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQeUtqSTNfRGUxYlh6X25uVGFQbmMwb1YxOW9MUUlXRDE4UW03cWU5ZndmQ19xNHVEUWpRTi0wLWlMS0FPTDZxQTltTjJPMHpNY0t0aGExemxXT0FnRVR2U3gyZXdmbFRpbUdwdUlDa1BYMEo1VFNDSWF1RzdldXd1MGdOa2lVZi1VOVh2Yjh2UE9vVEtnakhwSQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-04T23:38:28+00:00", "published_display": "04 Jul 2026 23:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mochida shares lean on business context as investors await new signals.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxOMTFMRmcxU3k3bGhxdXRma1g2NmtDUGFoWDNkT3M5Q2t0M09tZFQyM0EyUDJTbmJ5SmVkQ0lOZnA2N2FSVTg4ZlVvODJwQ0NfWGxlMFpWYjVkMzhiNENyeDlCbDRTdWlKdExkd3lGMHAtWllCSHVUdEMyczlzd252Y3BIMDlfN2ZjWkRad2NPUmVJaTJGX0FSajkya19yby0ydEF5aWdYcGp4UG5tcHZEa0YySXhXSWFnQkhXVEd0SUJDaXk5Ri1PMA?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T12:25:59+00:00", "published_display": "04 Jul 2026 12:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The CARP-III program from Mochida Pharmaceutical Co. - long-running B2B support for paediatric anaes", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNWmxXRmdBY2E2bjRZUklyX0N1ZDlkUDZDeVQ4OEFIdUpBU0VmcVkwSFBEMEczbzFxSkpGNmlUZDd2eGZDZjZZalo2UnpsYlJ4OTRVb21aUFNST0JOUWdYWFpCNzMwdVVYSlFEWlRpbnJ4MDZMbFdBQmpJWTh6a2MwdFNWTzRGc21lbHZSQmhYcUFuZ0Q3OVVFSUtSaG1ZNmV6clYtVGctZ1BiYW9kazYzdWlaTDNseUxkZEpCNEZucWl5WGpjRHc?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-27T23:11:17+00:00", "published_display": "27 Jun 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Mochida Pharmaceutical Co., Ltd. (TSE:4534)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5oeXFESW5wdENIamZtQVVxUWw4ZE5JbkpjZEluMkVGa3BoTWxPTlZzZlBPT1owcHVxY0ZvcV9fWERWajZBMXVFX0lIekt1SFV6ZUc0eW5tRzJpTUJEdzhEblNWek1SZVk?oc=5", "source_name": "TradingView", "published_at": "2018-02-02T23:10:44+00:00", "published_display": "02 Feb 2018 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 63, "total_relevant": 5, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 5, "score": 50, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 2.75, "count": 5}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 3135.0, "latest_week": "2026-07-10", "one_week_move": -0.5, "four_week_move": -2.0, "twelve_week_move": -12.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.235981, "market_dynamics_buy_signal": false, "relative_strength": -28.105776, "fair_value_gap": -1.3, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "positive", "expectation_probability": 59.1315, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.5% over one week, -2.0% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 49, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 3}, {"label": "ad-hoc-news.de", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.5% over one week, -2.0% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Enterprise value to EBITDA forward of Mochida Pharmaceutical Co., Ltd. \u2013 TSE:4534"}], "updated_at": "2026-07-17T10:22:13.668947+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}